BioPlus Acquisition Net Income

The latest net income for BIOS is $12M as of June 2023. That compares with $38K in the prior-year period — up 31469.2% year over year. That is below the sector sector average of $130M. Investors often review this figure alongside BioPlus Acquisition's historical trend and sector peers before judging valuation or financial health.

Over the past year, BIOS's net income moved from $38K to $12M — a 31469.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in BioPlus Acquisition's operating scale or balance-sheet position.

Against its sector companies, BIOS currently prints $12M for net income, while the sector average sits near $130M. That is roughly 91.0% below the sector mean. Large gaps often invite a closer look at BioPlus Acquisition's growth, margins, and balance sheet.

A net income figure of $12M for BIOS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $130M. Explore the charts below for those layers of context.

After noting BIOS's net income ($12M), review year-over-year change from $38K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.